We are live on
!
Find out more
ZCI
Zevenbergen Capital Investments Portfolio holdings
AUM
$4.38B
1-Year Est. Return
56.68%
This Fund
S&P 500
This Quarter
Est. Return
-20.63%
1 Year Est. Return
+56.68%
3 Year Est. Return
+239.32%
5 Year Est. Return
+232.55%
10 Year Est. Return
+3,491.87%
AUM
$2.29B
AUM Growth
-$856M
(-27%)
Cap. Flow
-$141M
Cap. Flow
% of AUM
-6.13%
Top 10 Holdings %
Top 10 Hldgs %
49.37%
Holding
89
New
6
Increased
40
Reduced
28
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trade Desk
TTD
|
+$40.9M |
| 2 |
Tilray
TLRY
|
+$22.1M |
| 3 |
NVIDIA
NVDA
|
+$19.3M |
| 4 |
SIEN
Sientra, Inc.
SIEN
|
+$15.5M |
| 5 |
PS
Pluralsight, Inc. Class A Common Stock
PS
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PFPT
Proofpoint, Inc.
PFPT
|
+$48.6M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
+$38.4M |
| 3 |
Take-Two Interactive
TTWO
|
+$33.8M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$31.9M |
| 5 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$30.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.95% |
| 2 | Consumer Discretionary | 25.27% |
| 3 | Communication Services | 19.33% |
| 4 | Healthcare | 13.94% |
| 5 | Financials | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
AbbVie
ABBV
$440B
| $250K | 0.01% |
2,712
| – | – |
|
77
iQIYI
IQ
$1.28B
| $187K | 0.01% |
+12,601
| New | +$263K |
|
|
FINV
78
FinVolution Group
FINV
$1.07B
| $72K | ﹤0.01% |
+20,058
| New | +$107K |
|
79
Carlisle Companies
CSL
$15.2B
| – | – |
-2,475
| Closed | -$301K |
|
80
JD.com
JD
$42.7B
| – | – |
-27,275
| Closed | -$712K |
|
|
RDFN
81
DELISTED
Redfin
RDFN
| – | – |
-49,240
| Closed | -$921K |
|
82
Sea Limited
SE
$78.5B
| – | – |
-96,450
| Closed | -$1.33M |
|
83
SLB Ltd
SLB
$78.1B
| – | – |
-4,105
| Closed | -$250K |
|
|
NVRO
84
DELISTED
NEVRO CORP.
NVRO
| – | – |
-673,480
| Closed | -$38.4M |
|
|
AVLR
85
DELISTED
Avalara, Inc.
AVLR
| – | – |
-212,480
| Closed | -$7.42M |
|
|
PFPT
86
DELISTED
Proofpoint, Inc.
PFPT
| – | – |
-456,869
| Closed | -$48.6M |
|
|
PTLA
87
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| – | – |
-1,137,055
| Closed | -$30.3M |
|
Similar funds
EQF
SFM
EC
FIS
CAU
NEI
IUHSA
CW
Zevenbergen Capital Investments's Q4 2018 Portfolio in Review
As of Q4 2018, Zevenbergen Capital Investments held 89 positions worth $2.29B, down 27% from $3.15B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Zevenbergen Capital Investments withdrew a net $141M in Q4 2018, closing 10 positions and reducing 28 holdings. Its most notable exit was Proofpoint, Inc., an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Zevenbergen Capital Investments opened a new position in Sientra, Inc. worth $10.6M.
- Zevenbergen Capital Investments's largest Q4 2018 buy was Sientra, Inc.: 83,358 shares worth $10.6M.
- Zevenbergen Capital Investments added most to Trade Desk in Q4 2018, an estimated $40.9M increase.
- Zevenbergen Capital Investments's biggest Q4 2018 reduction was Take-Two Interactive, cutting an estimated $33.8M.
- Zevenbergen Capital Investments fully exited Proofpoint, Inc. in Q4 2018, selling an estimated $48.6M.
- Zevenbergen Capital Investments's ten largest holdings make up 49% of its $2.29B portfolio in Q4 2018.
- Zevenbergen Capital Investments opened 6 new positions and closed 10 in Q4 2018.
- Zevenbergen Capital Investments's portfolio value fell 27% quarter-over-quarter to $2.29B.
Based on Zevenbergen Capital Investments's 13F filing for Q4 2018, filed 14 Feb 2019.